The latest award includes $37.9 million for CSL, $23.4 million for Sanofi and $10.5 million for GSK. It would more than double the country's supply of shots targeting bird flu, raising the country ...

Among the large drugmakers, Eli Lilly, AstraZeneca AZN, Pfizer PFE, Sanofi SNY and Bayer BAYRY are worth retaining ... at U.S ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

Additionally, some traditional flu vaccines are produced using eggs. Sanofi will ensure a steady supply of these vaccines to the United States to prepare for potential bird flu outbreaks and other ...

Sanofi has asked bidders to revise their proposals for its consumer health unit, people with knowledge of the matter said, as it considers whether to seek a sale or listing of the business. The ...

The drug and biotech sector has outperformed the broader equity market this year, backed by the launch of promising new ...

Also Read: FDA Approves Regeneron/Sanofi’s Blockbuster Dupixent For Smoker’s Lung Disease. The FDA approved the drug in 2022. Administered as chronic IV treatment. Enjaymo generated ...

“Sanofi is a global leader in immunological and inflammatory ... research and preclinical and clinical testing; disruptions in the supply chain, including raw materials needed for manufacturing and ...

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's ...

The latest award from the government, which includes $37.9 million for CSL, $23.4 million for Sanofi and $10.5 million for GSK, would more than double the United States' supply of shots targeting ...